Eli Lilly and

Yahoo Finance • yesterday

Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to lower... Full story

Yahoo Finance • yesterday

Market Chatter: Gates Foundation, PAHO Eye Expanded Access to Weight-Loss Drugs in Lower-Income Countries

The Gates Foundation and the Pan American Health Organization, or PAHO, are looking to expand access PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • yesterday

Bill Gates, PAHO consider ways to expand access to Wegovy and Mounjaro in low-income countries - report

[Diet pills on bathroom scales with bokeh and zoom effect] wwing/iStock via Getty Images * The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo Nordisk's (NVO [https:... Full story

Yahoo Finance • 2 days ago

Novo to buy Akero for up to $5.2 billion in new CEO's revival push

By Maggie Fick and Mariam Sunny (Reuters) -Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to gain access to a promising liver disease drug candidate, in the first major deal by the Danish d... Full story

Yahoo Finance • 3 days ago

Tariff turbulence deepens uncertainty across US supply chains

The Trump administration’s latest wave of import tariffs — ranging from a 25% duty on heavy-duty trucks to levies on industrial inputs and manufactured goods from China and India — are causing U.S. shippers and manufacturers to scramble fo... Full story

Yahoo Finance • 3 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index and the Health Car PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Sector Update: Health Care Stocks Advance Wednesday Afternoon

Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index adding 0.3% and the Hea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run

Hims & Hers Health is Wednesday's IBD Stock Of The Day. After returning to the IBD 50, Hims stock is making a second attempt at a breakout. Continue Reading View Comments... Full story

Yahoo Finance • 3 days ago

Harrow, Inc. (HROW): A Bull Case Theory

We came across a bullish thesis on Harrow, Inc. on Make Money, Make Time’s Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.'s share was trading at $47.88 as of September 24th. HRO... Full story

Yahoo Finance • 3 days ago

Is Eli Lilly’s Recent $1B India Investment a Game Changer for Its Valuation in 2025?

If you are watching Eli Lilly stock and wondering whether now is the time to buy, sell, or simply watch from the sidelines, you are not alone. The past few weeks have been a whirlwind, with shares bouncing back by 10.6% just this last week... Full story

Yahoo Finance • 3 days ago

Eli Lilly's Q3 Results Expected to Meet Estimates as Mounjaro Outperforms, Deutsche Bank Says

Eli Lilly (LLY) is projected to report Q3 results broadly in line with Wall Street expectations, dri PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Guggenheim Reaffirms Its Buy Rating on Eli Lilly & Company (LLY) with Price Target of $875

Eli Lilly & Company (NYSE:LLY) is one of the 10 Best Non-Tech Stocks to Buy According to Reddit, supported by hedge fund interest.Guggenheim Reaffirms Its Buy Rating on Eli Lilly & Company (LLY) with Price Target of $875 Eli Lilly & Compa... Full story

Yahoo Finance • 3 days ago

HealthTap Expands Access to Primary Care-Driven Diabetes Treatment Through LillyDirect®

HealthTap joins as the first independent telehealth primary care provider option available on LillyDirect®, offering patients living with type 1 and type 2 diabetes access to longitudinal primary care through its national medical group. S... Full story

Yahoo Finance • 3 days ago

Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ

[President Trump Signs Executive Order At The White House] Andrew Harnik/Getty Images News Family members of President Donald Trump and Commerce Secretary Howard Lutnick are set to profit as the U.S. government steps up its efforts to low... Full story

Yahoo Finance • 3 days ago

Clustermarket Rebrands to Calira and Secures Industry Veteran to Capitalise on Demand for Optimised R&D Lab Operations

Lab equipment scheduling platform supporting pharma and life sciences R&D organisations’ AI journey amidst industry upheaval LONDON, October 08, 2025--(BUSINESS WIRE)--Clustermarket, the lab equipment scheduling platform, has today announ... Full story

Yahoo Finance • 4 days ago

Former Top FDA Official, Forced Out by Kennedy, Lands at Eli Lilly

Dr. Peter Marks, the top Food and Drug Administration official whose forced resignation earlier this year set off a panic among biotech investors, is now an executive at Eli Lilly the company said on Tuesday. Marks stepped down as the chie... Full story

Yahoo Finance • 4 days ago

Acadia Healthcare Appoints Todd Young as Chief Financial Officer

Young Brings 25 Years of Financial and Healthcare Industry Experience FRANKLIN, Tenn., October 07, 2025--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) ("Acadia" or the "Company") today announced the appointment of Todd Y... Full story

Yahoo Finance • 4 days ago

Novo Nordisk Cuts Jobs At Key U.S. Drug Plant

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) has laid off dozens of employees at its biggest U.S. manufacturing site in North Carolina, according to LinkedIn posts reviewed by Reuters. The cuts affected workers in rol... Full story

Yahoo Finance • 4 days ago

Eli Lilly reports positive results from ulcerative colitis trial

[Interior of a medical consulting room] Luis Alvarez Eli Lilly (NYSE:LLY [https://seekingalpha.com/symbol/LLY]) announced positive results from a late-stage trial of Omvoh (mirikizumab-mrkz) for patients suffering from moderately to sever... Full story

Yahoo Finance • 4 days ago

‘People are desperate’: how Mounjaro users are beating the price rise

Sarah le Brocq’s Mounjaro prescription has jumped in price by more than £200 per month - Asadour Guzelian In January, when Sarah le Brocq signed up for a year’s supply of weight loss jab Mounjaro at £99 per month, it felt like a good deal... Full story